Melanoma patients in a phase I clinic: molecular aberrations, targeted therapy and outcomes.
about
Unique molecular signatures as a hallmark of patients with metastatic breast cancer: implications for current treatment paradigmsImpact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials.Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-analysis of Clinical Trials Leading to FDA ApprovalThe Conundrum of Genetic "Drivers" in Benign Conditions.Non-BRAF-targeted therapy, immunotherapy, and combination therapy for melanoma.Molecular aberrations, targeted therapy, and renal cell carcinoma: current state-of-the-art.Value-based genomics.
P2860
Q33756991-47D90CFC-BBA8-43DA-BE46-FBFEE80E9ADCQ36534696-8AC1EBC9-7CEA-4D55-8321-78E745403598Q36871001-A5788E67-0991-4716-902B-74E365BADD8EQ37245787-BB81EEB1-AA00-434B-A06A-EA594A1CEDC8Q38195656-7C0781A6-BB45-427D-BEDF-9BD3CFD0CECAQ38264616-5654023C-0A59-4258-A5C0-F1D2E12A9825Q55339672-033C93B0-A30C-4E86-96AF-148B9E2B9BD8
P2860
Melanoma patients in a phase I clinic: molecular aberrations, targeted therapy and outcomes.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Melanoma patients in a phase I ...... targeted therapy and outcomes.
@ast
Melanoma patients in a phase I ...... targeted therapy and outcomes.
@en
type
label
Melanoma patients in a phase I ...... targeted therapy and outcomes.
@ast
Melanoma patients in a phase I ...... targeted therapy and outcomes.
@en
prefLabel
Melanoma patients in a phase I ...... targeted therapy and outcomes.
@ast
Melanoma patients in a phase I ...... targeted therapy and outcomes.
@en
P2093
P2860
P50
P356
P1433
P1476
Melanoma patients in a phase I ...... targeted therapy and outcomes
@en
P2093
G C George
G S Falchook
R Kurzrock
P2860
P304
P356
10.1093/ANNONC/MDT115
P577
2013-04-10T00:00:00Z